Aqsens Health and Research Teams from Nanjing and Shanghai Replicate Large-Scale Prostate Cancer Cohort Measurements in China
Aqsens Health’s team traveled to Shanghai in early July to conduct prostate cancer analyses in collaboration with research teams from Nanjing and Shanghai. The goal of the trip was to analyze a large, well-designed urine sample cohort using the latest phage-biosensors and protocols, replicating insights gained in Finland. The Aqsens team also trained the Chinese research teams to continue the work independently after their return. This collaboration combines Finnish biotech innovation with China’s research talent, advanced capabilities, and strong interest in urine-based analysis.
Why bladder cancer gets missed, and why that needs to change – Bladder Cancer Awareness Month 2025
Bladder cancer is the 9th most common cancer in the world. In 2022, an estimated 614,000 new cases were diagnosed and over 1,9 million people were living with bladder cancer within five years of a past diagnosis . Every May the World Bladder Cancer Patient Coalition celebrates bladder cancer awareness month. Urinary tract cancers, including bladder cancer, are our main research focus here at Aqsens Health, which is why this year we wanted to take part in raising awareness for bladder cancer.
What matters most is the beautiful mind of the scientist – International Day of Women and Girls in Science 2025
Since 2015, February 11th has been celebrated as the UN Day for Women and Girls in Science and Technology, a day dedicated to highlighting the achievements of women in STEM and inspiring future generations to follow their lead. In previous years, we’ve heard from incredible women like our COO Vilhelmiina Juusti and Senior Application Scientist Elizabeth Cudjoe. This year, we are excited to spotlight Elinda Hermanson, our newest Application Scientist, who shares her journey in biotechnology and her thoughts on empowering women in science.
Nordic Tech and Innovation leader Pia Erkinheimo Appointed Chairperson of the Board at Aqsens Health – An Interview with Pia Erkinheimo
Aqsens Health, the inventor of the groundbreaking phage-biosensor method, is pleased to announce the appointment of Pia Erkinheimo as the Chairperson of the Board of Directors. Her leadership roles in high tech, experience in building up businesses, and connections to the innovation ecosystems both in the Nordics and Europe will open up new opportunities for Aqsens Health and complement our board of directors with valuable insights.